Pacira BioSciences [PCRX] vs Zoetis [ZTS] Detailed Stock Comparison

Pacira BioSciences

NASDAQ
Loading...

Zoetis

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Pacira BioSciences wins in 10 metrics, Zoetis wins in 9 metrics, with 0 ties. Pacira BioSciences appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricPacira BioSciencesZoetisBetter
P/E Ratio (TTM)13.1425.16Pacira BioSciences
Price-to-Book Ratio1.4713.06Pacira BioSciences
Debt-to-Equity Ratio83.32137.01Pacira BioSciences
PEG Ratio-0.101.44Pacira BioSciences
EV/EBITDA8.2217.80Pacira BioSciences
Profit Margin (TTM)-18.06%27.83%Zoetis
Operating Margin (TTM)5.04%40.20%Zoetis
EBITDA Margin (TTM)5.04%40.20%Zoetis
Return on Equity-15.57%52.77%Zoetis
Return on Assets (TTM)2.69%15.37%Zoetis
Free Cash Flow (TTM)$178.75M$2.30BZoetis
Dividend YieldN/A1.11%N/A
1-Year Return45.62%-22.95%Pacira BioSciences
Price-to-Sales Ratio (TTM)1.586.91Pacira BioSciences
Enterprise Value$1.30B$70.26BZoetis
EV/Revenue Ratio1.847.49Pacira BioSciences
Gross Profit Margin (TTM)77.43%73.62%Pacira BioSciences
Revenue per Share (TTM)$15$21Zoetis
Earnings per Share (Diluted)$-2.75$5.82Zoetis
Beta (Stock Volatility)0.410.90Pacira BioSciences
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Pacira BioSciences vs Zoetis Stock Performance Analysis

Loading Price Chart...

Pacira BioSciences
Zoetis
Pacira BioSciences Stock Overview | Zoetis Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Pacira BioSciences-1.05%-8.34%-11.67%1.72%3.10%28.86%
Zoetis1.51%2.03%-3.94%-8.02%-8.26%-9.96%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Pacira BioSciences45.62%-54.22%-57.81%-40.31%235.99%235.99%
Zoetis-22.95%-0.64%-11.49%242.10%372.17%372.17%

News Based Sentiment: Pacira BioSciences vs Zoetis

Pacira BioSciences

News based Sentiment: POSITIVE

Pacira BioSciences' decision to grant inducement awards to new employees signals confidence in future growth and a commitment to attracting top talent. The structured vesting schedules of both stock options and RSUs are designed to align employee interests with long-term shareholder value, which is a positive indicator for investors.

View Pacira BioSciences News Sentiment Analysis

Zoetis

News based Sentiment: MIXED

The month featured both positive developments – the CVMP opinion for Portela® and generally positive analyst estimates – alongside negative signals like stock decline, technical warnings, and mixed institutional activity. This creates a balanced, rather than decisively positive or negative, investment narrative.

View Zoetis News Sentiment Analysis

Performance & Financial Health Analysis: Pacira BioSciences vs Zoetis

MetricPCRXZTS
Market Information
Market Cap i$1.12B$65.09B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i417,9553,169,830
90 Day Avg. Volume i581,7252,720,843
Last Close$23.62$167.10
52 Week Range$15.16 - $27.64$139.70 - $200.33
% from 52W High-14.54%-16.59%
All-Time High$121.95 (Feb 23, 2015)$249.27 (Dec 27, 2021)
% from All-Time High-80.63%-32.96%
Growth Metrics
Quarterly Revenue Growth0.02%0.04%
Quarterly Earnings Growth0.02%0.15%
Financial Health
Profit Margin (TTM) i-0.18%0.28%
Operating Margin (TTM) i0.05%0.40%
Return on Equity (TTM) i-0.16%0.53%
Debt to Equity (MRQ) i83.32137.01
Cash & Liquidity
Book Value per Share (MRQ)$16.88$11.21
Cash per Share (MRQ)$9.92$3.28
Operating Cash Flow (TTM) i$134.52M$2.93B
Levered Free Cash Flow (TTM) i$108.49M$2.29B
Dividends
Last 12-Month Dividend Yield iN/A1.11%
Last 12-Month Dividend iN/A$1.86

Valuation & Enterprise Metrics Analysis: Pacira BioSciences vs Zoetis

MetricPCRXZTS
Price Ratios
P/E Ratio (TTM) i13.1425.16
Forward P/E i8.2023.09
PEG Ratio i-0.101.44
Price to Sales (TTM) i1.586.91
Price to Book (MRQ) i1.4713.06
Market Capitalization
Market Capitalization i$1.12B$65.09B
Enterprise Value i$1.30B$70.26B
Enterprise Value Metrics
Enterprise to Revenue i1.847.49
Enterprise to EBITDA i8.2217.80
Risk & Other Metrics
Beta i0.410.90
Book Value per Share (MRQ) i$16.88$11.21

Financial Statements Comparison: Pacira BioSciences vs Zoetis

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)PCRXZTS
Revenue/Sales i$168.92M$2.22B
Cost of Goods Sold i$34.31M$622.00M
Gross Profit i$134.62M$1.60B
Research & Development i$25.34M$157.00M
Operating Income (EBIT) i$8.18M$846.00M
EBITDA i$39.80M$991.00M
Pre-Tax Income i$8.71M$810.00M
Income Tax i$3.89M$179.00M
Net Income (Profit) i$4.81M$631.00M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)PCRXZTS
Cash & Equivalents i$283.61M$1.72B
Total Current Assets i$759.96M$5.88B
Total Current Liabilities i$314.73M$3.39B
Long-Term Debt i$424.97M$5.40B
Total Shareholders Equity i$798.54M$4.66B
Retained Earnings i$-201.54M$12.38B
Property, Plant & Equipment i$48.73M$6.36B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)PCRXZTS
Operating Cash Flow i$37.87M$567.00M
Capital Expenditures i$-8.55MN/A
Free Cash Flow i$26.91M$438.00M
Debt Repayment i$-2.81MN/A
Common Stock Repurchase iN/A$-443.00M

Short Interest & Institutional Ownership Analysis

MetricPCRXZTS
Shares Short i6.69M9.19M
Short Ratio i10.253.71
Short % of Float i0.21%0.02%
Average Daily Volume (10 Day) i417,9553,169,830
Average Daily Volume (90 Day) i581,7252,720,843
Shares Outstanding i46.24M448.47M
Float Shares i39.82M442.31M
% Held by Insiders i0.02%0.00%
% Held by Institutions i1.16%0.99%

Dividend Analysis & Yield Comparison: Pacira BioSciences vs Zoetis

MetricPCRXZTS
Last 12-Month Dividend iN/A$1.86
Last 12-Month Dividend Yield iN/A1.11%
3-Year Avg Annual Dividend iN/A$1.63
3-Year Avg Dividend Yield iN/A0.24%
3-Year Total Dividends iN/A$4.90
Ex-Dividend DateN/AApr 21, 2025